Ficus carica leaf extract modulates the lipid profile of rats fed with a high-fat diet through an increase of HDL-C

Phytotherapy Research

Volumn 28, Issue 2, 2014, Pages 261-267

  Joerin, Lorenz ^a   Kauschka, Michaela ^b   Bonnländer, Bernd ^c   Pischel, Ivo ^b   Benedek, Birgit ^b   Butterweck, Veronika ^a,d  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b PhytoLab GmbH   (Germany)

^c Plantextrakt GmbH and Co   (Germany)

^d UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

dyslipidemia; Ficus carica; HDL C; metabolic syndrome

Indexed keywords

DYSLIPIDEMIA; FICUS CARICA; HDL-C; METABOLIC SYNDROME;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, HIGH-FAT; FICUS; HYPERLIPIDEMIAS; INSULIN; INTERLEUKIN-6; LEPTIN; MALE; OBESITY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 84893745537     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4994     Document Type: Article

References (48)

1. Acheson KJ, Campbell IT, Edholm OG, Miller DS, Stock MJ,. 1980. A longitudinal study of body weight and body fat changes in Antarctica. Am J Clin Nutr 33: 972-977.
2. Adeneye AA, Adeyemi OO, Agbaje EO,. 2010. Anti-obesity and antihyperlipidaemic effect of Hunteria umbellata seed extract in experimental hyperlipidaemia. J Ethnopharmacol 130: 307-314.
3. Asadi F, Pourkabir M, MacLaren R, Shahriari A,. 2006. Alterations to lipd parameters in response to Fig tree (Ficus carica) leaf extract in chicken liver slices. Turk J Vet Anim Sci 30: 315-318.
4. Barter PJ, Baker PW, Rye KA,. 2002. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol 13: 285-288.
5. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM,. 2004. Antiinflammatory properties of HDL. Circ Res 95: 764-772.
6. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM,. 2002. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22: 1668-1673.
7. Butterweck V, Nahrstedt A,. 2012. What Is the Best Strategy for Preclinical Testing of Botanicals? A Critical Perspective. Planta Med 78: 747-54.
8. Canal JR, Torres MD, Romero A, Perez C,. 2000. A chloroform extract obtained from a decoction of Ficus carica leaves improves the cholesterolaemic status of rats with streptozotocin-induced diabetes. Acta Physiol Hung 87: 71-76.
9. Chawla A, Kaur R, Sharma AK,. 2012. Ficus carica Linn.: A review on its pharmacognostic, phytochemical and pharmacological aspects. Int J Pharm Phytopharm Res 1: 215-232.
10. Daskalopoulou SS, Mikhailidis DP, Elisaf M,. 2004. Prevention and treatment of the metabolic syndrome. Angiology 55: 589-612.
11. Dobiasova M,. 2004. Atherogenic index of plasma [log(triglycerides/HDL- cholesterol)]: theoretical and practical implications. Clin Chem 50: 1113-1115.
12. Dominguez E, Cannal DM, Torres DM, Compillo EJ, Perrez C,. 1996. Hypolipidaemic activity of Ficus carica L. etract in streptozotocin-diabetic rats. Phytother Res 10: 526-528.
13. El-Shobaki FA, El-Bahay AM, Esmail RSA, Agd El Megeid AA, Esmail NS,. 2010. Effect of figs fruit (Ficus carica L.) and its leaves on hyperglycemia in alloxan diabetic rats. World J Dairy Food Sci 5: 47-57.
14. Fatemi A, Rasouli A, Asadi F,. 2007. Effect of fig leaf (Ficus carica) lextract on the secretion and content of cholesterol in HEPG2 cell. Am J Anim Vet Sci 2: 104-107.
15. Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS,. 2011. Emerging options in the treatment of dyslipidemias: a bright future? Expert Opin Emerg Drugs 16: 247-270.
16. Frerot E, Decorzant E,. 2004. Quantification of total furocoumarins in citrus oils by HPLC coupled with UV, fluorescence, and mass detection. J Agric Fodd Chem 52: 6879-6886.
17. Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC Jr., Lenfant C,. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438.
18. Joy TR,. 2012. Novel HDL-based therapeutic agents. Pharmacol Ther 135: 18-30.
19. Jung CH, Cho I, Ahn, J, Jeon TI, Ha TY,. 2013. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res 27: 139-143.
20. Kajikawa Y, Ikeda M, Takemoto S, Tomoda J, Ohmaru N, Kusachi S,. 2011. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J 52: 17-22.
21. Kang JS, Lee WK, Yoon WK, et al,. 2011. A combination of grape extract, green tea extract and L-carnitine improves high-fat diet-induced obesity, hyperlipidemia and non-alcoholic fatty liver disease in mice. Phytother Res 25: 1789-1795.
22. Kapiotis S, Holzer G, Schaller G, et al,. 2006. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 26: 2541-2546.
23. Kim HJ, Jeon SM, Lee MK, et al,. 2010. Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters. J Med Food 13: 808-814.
24. Kinosian B, Glick H, Preiss L, Puder KL,. 1995. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med 43: 443-450.
25. Kurowska EM, Spence JD, Jordan J, et al,. 2000. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72: 1095-1100.
26. Lender D, Sysko SK,. 2006. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Pharmacotherapy 26: 3S-12S.
27. Lin TY, Liao JW, Chang ST, Wang SY,. 2011. Antidyslipidemic Activity of Hot-water Extracts from Leaves of Cinnamomum osmophloeum Kaneh. Phytother Res, in press: doi: 10.1002/ptr.3408
28. Liu IM, Tzeng TF, Liou SS, Chang CJ,. 2012. Regulation of obesity and lipid disorders by extracts from Angelica acutiloba root in high-fat diet-induced obese rats. Phyother Res 26: 223-230.
29. Moller DE,. 2001. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414: 821-827.
30. Nakajima K,. 2010. Pharmacotherapy of mixed dyslipidemia in the metabolic syndrome. Curr Clin Pharmacol 5: 133-139.
31. Nammi S, Sreemantula S, Roufogalis BD,. 2009. Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic Clin Pharmacol Toxicol 104: 366-373.
32. Okura H, Yamashita S, Ohama T,. 2010. HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins. J Atheroscler Thromb 17: 568-577.
33. Perez C, Canal JR, Campillo JE, Romero A, Torres MD,. 1999. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytother Res 13: 188-191.
34. Perez C, Canal JR, Torres MD,. 2003. Experimental diabetes treated with ficus carica extract: effect on oxidative stress parameters. Acta Diabetol 40: 3-8.
35. Perez C, Dominguez E, Canal JR, Campillo JE, Torres MD,. 2000. Hypoglycaemic activity of an aqueous extract from Ficus carica (fig tree) leaves in streptozotocin diabetic rats. Pharm Biol 38: 181-186.
36. Redondo S, Martinez-Gonzalez J, Urraca C, Tejerina T,. 2011. Emerging therapeutic strategies to enhance HDL function. Lipids Health Dis 10: 175.
37. Serraclara A, Hawkins F, Perez C, Dominguez E, Campillo JE, Torres MD,. 1998. Hypoglycemic action of an oral fig-leaf decoction in type-I diabetic patients. Diabetes Res Clin Pract 39: 19-22.
38. Sharabi Y, Oron-Herman M, Kamari Y, et al,. 2007. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hypertens 20: 206-210.
39. Srinivasan K, Patole PS, Kaul CL, Ramarao P,. 2004. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26: 327-333.
40. Stelzer I, Zelzer S, Raggam RB, et al,. 2012. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res 159: 118-124.
41. Tenenbaum A, Fisman EZ, Motro M,. 2003. Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc Diabetol 2: 4.
42. Torres Maldonado LC, Dominguez E, Romero A, Campillo JE, Perez C,. 1993. Hypoglycemic and hypolipidemic activity of an aqueous extract from Ficus carica in streptozotocin-diabetic. Diabetologia 36 (Suppl.1): A 181-182.
43. Toyama T, Kudo N, Hibino Y, Mitsumoto A, Nishikawa M, Kawashima Y,. 2007. Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats. J Pharmacol Sci 104: 137-145.
44. Tschop M, Heiman ML,. 2001. Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes 109: 307-319.
45. Vikram A, Jena G, Ramarao P,. 2010. Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia. Br J Pharmacol 161: 1708-1721.
46. Yamagishi S, Adachi H, Matsui T, et al,. 2009. Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population. Clin Cardiol 32: E29-32.
47. Young GS, Kirkland JB,. 2007. Rat models of caloric intake and activity: relationships to animal physiology and human health. Appl Physiol Nutr Metab 32: 161-176.
48. Zhu X, Zhang W, Pang X, Wang J, Zhao J, Qu W,. 2011. Hypolipidemic effect of n-butanol Extract from Asparagus officinalis L. in mice fed a high-fat diet. Phytother Res 25: 1119-1124.